Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · IEX Real-Time Price · USD
4.675
+0.035 (0.75%)
Apr 26, 2024, 10:36 AM EDT - Market open
Terns Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for TERN stock have an average target of 14.94, with a low estimate of 5.50 and a high estimate of 23. The average target predicts an increase of 219.57% from the current stock price of 4.68.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 27, 2024.
Analyst Ratings
The average analyst rating for TERN stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +285.03% | Mar 27, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $17 → $15 | Buy | Maintains | $17 → $15 | +220.86% | Mar 18, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $18 → $19 | Buy | Maintains | $18 → $19 | +306.42% | Mar 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5.5 | Hold | Reiterates | $5.5 | +17.65% | Mar 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $8 → $5.5 | Hold | Maintains | $8 → $5.5 | +17.65% | Jan 10, 2024 |
Financial Forecast
Revenue This Year
1.71M
Revenue Next Year
2.96M
from 1.71M
Increased by 73.49%
EPS This Year
-1.41
from -1.27
EPS Next Year
-1.45
from -1.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.3M | 16.0M | 86.6M | 356.5M | 752.4M |
| Avg | 1.7M | 3.0M | 17.8M | 95.8M | 194.6M |
| Low | n/a | n/a | n/a | n/a | 3.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 836.1% | 2,828.5% | 1,903.9% | 685.4% |
| Avg | - | 73.5% | 501.4% | 438.6% | 103.1% |
| Low | - | - | - | - | -96.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.23 | -0.97 | -0.58 | -0.74 | -0.22 |
| Avg | -1.41 | -1.45 | -1.14 | -1.13 | -1.04 |
| Low | -1.60 | -1.86 | -1.58 | -1.70 | -1.90 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.